At a glance
- Originator Otsuka Pharmaceutical
- Class Antihyperglycaemics; Small molecules; Thiadiazoles; Thiazolidines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetic complications